Compounding Pharmacy Draws Warning Letter for Misbranded, Unapproved Drugs

Drug Industry Daily
A A
The FDA Philadelphia district office has issued a warning letter to a compounding pharmacy in Allentown, PA over misbranded drugs and sterility issues.

To View This Article:

Login

Subscribe To Drug Industry Daily